Transcatheter aortic valve thrombosis: The more we see the more we know
- PMID: 34369056
- DOI: 10.1002/ccd.29845
Transcatheter aortic valve thrombosis: The more we see the more we know
Comment on
-
Transcatheter aortic valve thrombosis: Data from a French multicenter cohort analysis.Catheter Cardiovasc Interv. 2021 Aug 1;98(2):352-362. doi: 10.1002/ccd.29555. Epub 2021 Feb 21. Catheter Cardiovasc Interv. 2021. PMID: 33615701
References
REFERENCES
-
- Ten Berg J, Sibbing D, Rocca B, et al. Management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation: a consensus document of the ESC working group on thrombosis and the European Association of Percutaneous Cardiovascular Interventions (EAPCI), in collaboration with the ESC Council on Valvular heart disease. Eur Heart J. 2021;42(23):2265-2269.
-
- Latib A, Naganuma T, Abdel-Wahab M, et al. Treatment and clinical outcomes of transcatheter heart valve thrombosis. Circ Cardiovasc Interv. 2015;8(4):e001779.
-
- Franzone A, Pilgrim T, Haynes AG, et al. Transcatheter aortic valve thrombosis: incidence, clinical presentation and long-term outcomes. Eur Heart J Cardiovasc Imaging. 2018;19(4):398-404.
-
- Mouyen T, Manigold T, Collet JP, et al. Transcatheter aortic valve thrombosis: data from a French multicenter cohort analysis. Catheter Cardiovasc Interv. 2021;98:352-362.
-
- Généreux P, Piazza N, Alu MC, et al. Valve academic research consortium 3: updated endpoint definitions for aortic valve clinical research. J Am Coll Cardiol. 2021;77(21):2717-2746.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical